rs1131690889
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000321.3(RB1):c.1251_1252delAA(p.Arg418SerfsTer9) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. K417K) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000321.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- hereditary retinoblastomaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
- retinoblastomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- melanomaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RB1 | NM_000321.3 | c.1251_1252delAA | p.Arg418SerfsTer9 | frameshift_variant | Exon 13 of 27 | ENST00000267163.6 | NP_000312.2 | |
| RB1 | NM_001407165.1 | c.1251_1252delAA | p.Arg418SerfsTer9 | frameshift_variant | Exon 13 of 27 | NP_001394094.1 | ||
| RB1 | NM_001407166.1 | c.1251_1252delAA | p.Arg418SerfsTer9 | frameshift_variant | Exon 13 of 17 | NP_001394095.1 | ||
| LOC112268118 | XR_002957522.2 | n.41-2712_41-2711delTT | intron_variant | Intron 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1251_1252delAA pathogenic mutation, located in coding exon 13 of the RB1 gene, results from a deletion of two nucleotides between positions 1251 and 1252, causing a translational frameshift with a predicted alternate stop codon. This mutation was previously identified in one individual diagnosed with bilateral retinoblastoma at age 3 months (Abouzeid H et al. Mol. Vis. 2007;13:1740-5). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at